Biotech IPO Boom Gaining Thrust With NantKwest Debut

A hot market for biotech IPOs is about to get hotter with the upcoming debut of NantKwest, a developer of cancer therapies that could set a record for market valuation. NantKwest (NK) will be the 51st initial public offering in the health care field this year if it prices Monday evening as planned. That's more than triple the next most active sectors, technology and finance, with 15 IPOs each. Health care also had the most IPOs last year, at 102.

What feeling does this article give you?

#hashtags to follow:

IPOs [+]    NantKwest [+]    Monday [+]   

More #news: